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Abstract
Background:  In search of new antifungal targets of potential interest for pharmaceutical
companies, we initiated a comparative genomics study to identify the most promising protein-
coding genes in fungal genomes. One criterion was the protein sequence conservation between
reference pathogenic genomes. A second criterion was that the corresponding gene in
Saccharomyces cerevisiae should be essential. Since thiamine pyrophosphate is an essential product
involved in a variety of metabolic pathways, proteins responsible for its production satisfied these
two criteria.
Results: We report the enzymatic characterization and the crystallographic structure of the
Candida albicans Thiamine pyrophosphokinase. The protein was co-crystallized with thiamine or
thiamine-PNP.
Conclusion: The presence of an inorganic phosphate in the crystallographic structure opposite
the known AMP binding site relative to the thiamine moiety suggests that a second AMP molecule
could be accommodated in the C. albicans structure. Together with the crystallographic structures
of the enzyme/substrate complexes this suggests the existence of a secondary, less specific,
nucleotide binding site in the Candida albicans thiamine pyrophosphokinase which could transiently
serve during the release or the binding of ATP. The structures also highlight a conserved Glutamine
residue (Q138) which could interact with the ATP α-phosphate and act as gatekeeper. Finally, the
TPK/Thiamine-PNP complex is consistent with a one step mechanism of pyrophosphorylation.
Background
Our laboratory runs a structural genomics project (PRO-
FUN [1]) targeting fungal protein-coding genes in search
of new anti-fungal targets. The main goal of this project is
to quantitatively express the selected Saccharomyces cerevi-
siae and Candida albicans genes products to characterize
them functionally and structurally as well as explore their
potential as new drug targets. The genes selected in Cand-
ida albicans are of two types: 1) they have orthologous
genes in Saccharomyces cerevisiae that are essential or 2)
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they are conserved in pathogenic fungal genomes and can
be absent from the non-pathogenic yeast Saccharomyces
cerevisiae.
Candida albicans is a diploid organism with eight sets of
homologous chromosomes and a genome size of about
32 Mb. This pathogen is part of the normal microflora of
the human gastrointestinal tract or oropharynx and is
responsible for various nosocomial infections, potentially
lethal in immunocompromised patients or patients in the
intensive care unit. The CA1462 protein is encoded by a
gene conserved across all known fungal genomes. It shares
36% sequence identity with Saccharomyces cerevisiae
YOR143C [2], a Thiamine pyrophosphokinase (TPK, EC
2.7.6.2) essential for fungus growth and survival [3]. This
enzyme is also essential in S. pombe [4]. The production of
thiamine pyrophosphate (TPP), catalyzed by TPK, is criti-
cal for both catabolic and anabolic cellular processes. In
vertebrates, a deficiency in thiamine synthesis is linked to
neurological diseases such as beriberi and Wernicke
encephalopathy [5]. In all synthesizing organisms, thia-
mine (vitamin B1) is produced from phosphorylated HET
(4-methyl-5-(β-hydroxymethyl)thiazole) and HMP (2-
methyl-4-amino-5-hydroxymethyl-pyrimidine) that are
condensed into thiamine phosphate. In yeast, this thia-
mine phosphate is then hydrolyzed into thiamine before
pyrophosphorylation by the TPK that catalyzes the trans-
fer of a pyrophosphate (PPi) from ATP to thiamine, result-
ing in AMP and TPP [6].
This article reports the enzymatic characterization as well
as the structure determination of the Candida albicans
CA1462 Thiamine pyrophosphokinase in complex with
both thiamine and thiamine-PNP (TPNP). We also
present a comparison of CA1462 with the structure of the
mouse TPK ternary complex with pyrithiamine pyrophos-
phate and AMP (PDB id 2F17) [7], with the TPK S. cerevi-
siae structure (PDB id 1IG0) [8] and with sequences from
other species.
Methods
General cloning strategy
The cDNAs corresponding to the TPK genes were ampli-
fied by PCR from their respective genomic DNAs
(CA1462:  Candida albicans strain NIH 3147 ATCC
number MYA-2876D; YOR143C:Saccharomyces cerevisiae
strain NRRL Y-53 ATCC number 2601D-5). Gene cloning
was performed using the ligation-independent cloning
(LIC) method based on ligation of sticky ends generated
by T4 DNA polymerase [9]. For the purpose of the PRO-
FUN project, we constructed a specific expression vector,
pSF-04 (see Additional file 1) Patent [10], compatible
with LIC cloning using the following procedure. The
EcoRI+BamHI region of PQE60 was inserted in pQE80L
vector where XhoI, NcoI and MfeI sites have been mutated.
Then the LacZ encoding gene was PCR amplified using
primers containing flanking sequences (represented in
bold) used for LIC cloning:
5'-CCATGGCTcatcaccatcaccatcacGGGCATCACCAT-
CAATTG, forward primer containing the coding sequence
(lower case) for a poly-histidine tag,
5'-GGATCCCTCGAGTTAGTCACCATCCAATTG, reverse
primer.
In the absence of an insert, the pSF-04 expression vector
expresses the lacz gene, while the in frame insertion of the
resulting PCR products into NcoI+BamHI sites deactivates
the gene thus allowing the easy detection of the parental
vector [10]. In addition; the GFP encoding gene was PCR-
amplified using primers containing flanking sequences 5'-
CTCGAGGCGGCCG  and 5'-GGATCCATTATGCG-
GCCGC. This PCR product was inserted at the 3'end of the
LacZ encoding gene into XhoI+BamHI sites yielding the
pSF-04 expression vector that expresses the GFP in C-ter-
minal fusion with the targeted gene. Not1 restriction sites
(GCGGCCGC) flanking the GFP encoding gene allows its
removal [10].
Cloning and expression screening of CA1462 and 
YOR143C TPK genes
PCR amplifications were performed using primers specific
for CA1462 and YOR143C TPK genes preceded by 5'-CAT-
CACCATCAATTG (Direct primer) and 5'-TCACCATC-
CAATTG (Reverse Primer) together with purified Candida
albicans and Saccharomyces cerevisiae genomic DNA as tem-
plate. The PCR products were directly purified using the
NucleoSpin Extract kit (Macherey Nagel). Then 0.2 pmol
of the purified PCR product was treated with T4 DNA
polymerase in the presence of 2.5 mM of dCTP for 30
min. at 22°C before inactivating the enzyme by heating
20 min at 75°C. In a parallel procedure, the expression
vector, pSF-04, was digested with the Mfel restriction
enzyme to excise the insert bearing the lacZ encoding
sequence. pSF-04 was then purified on agarose gel using
the NucleoSpin Extract kit (Macherey Nagel) and treated
with T4 DNA polymerase in the presence of 2.5 mM of
dGTP for 30 min at 22°C before inactivating the enzyme
by heating 20 min. at 75°C.
The cloning step of the two fungi TPK genes consisted in a
hybridization reaction performed by mixing 0.01 pmol of
pSF-04 and 0.02 pmol of the insert in a reaction volume
of 3 μl and an incubation time of 5 min. at 22°C, 1 μl of
25 mM EDTA was then added to the reaction mixture.
After a second incubation period of 5 min. at 22°C, the
entire hybridization reaction was used to transform E. coli
DH5α. Selection was performed on LB plates containing
100 μg/ml ampicillin, positive plasmids were then iso-BMC Structural Biology 2008, 8:33 http://www.biomedcentral.com/1472-6807/8/33
Page 3 of 14
(page number not for citation purposes)
lated. This cloning procedure allowed insertion of the
gene of interest in frame with a sequence encoding the N-
terminal (His)6 tag and a GHHHQL sequence correspond-
ing to the translation of the forward primer sequence. An
additional C-terminal fragment QLDGDLEAA corre-
sponds to the translation of a linker between the gene of
interest and the sequence encoding the GFP.
An expression screening was performed using our stand-
ard procedure [11] and the GFP gene reporter was used to
quantify the soluble expression through fluorescence
measurements [12] in order to identify the best condition
for the fungi TPK proteins soluble expression. Subsequent
removal of the GFP encoding gene was achieved by digest-
ing the plasmid by NotI followed by intra ligation.
As a result, the plasmids carrying the CA1462 gene were
over-expressed in E. coli Origami in 1L flasks containing
SB medium cultured overnight at 17°C. Induction was
performed using IPTG (500 μM) when the culture reached
an OD600 nm of 0.5. The plasmids carrying the YOR143C
gene were expressed in E. coli Origami in 1L flasks con-
taining 2YTG medium at 25°C after induction with IPTG
(500 μM) when the culture reached an OD600 nm of 0.5.
After centrifugation, the pellets were resuspended in
buffer A (50 mM NaH2PO4, 300 mM NaCl pH 8.0) with
5 % glycerol and 0.1 % Triton X-100 then sonicated and
centrifuged again.
Purification
The cleared lysate was applied to a 5 ml HiTrap Chelating
Column (GE Healthcare) loaded with Ni2+ and equili-
brated with buffer A. The column was washed with 10 col-
umn volumes of buffer A, 10 column volumes of buffer A
containing 25 mM Imidazole and 5 column volumes of
buffer A containing 50 mM Imidazole at a flow rate of 1
ml.min-1. Elution was performed with a linear gradient
over 7 column volumes from 50 mM to 500 mM Imida-
zole. The fractions corresponding to the elution of
CA1462 and YOR143 TPK proteins with 150–200 mM
Imidazole were run on a desalting column (Fast Desalting
Column HR 10/10, Pharmacia) and analyzed by mass
spectroscopy and N-terminal Edman sequencing. After
purification, the fractions contained at least 98% pure
protein in Tris buffer 10 mM pH 8 (CA1462) and Tris
buffer 20 mM, 100 mM NaCl pH 8 (YOR143). For the
CA1462 protein, the isoelectrofocalisation revealed a
band around 6.0 instead of the predicted pI of 5.4. Gel fil-
tration of the purified TPK proteins on a Sephacryl S200
HR column indicated the final products were dimeric in
solution.
Enzymatic assays
In order to verify that our two C. albicans and S. cerevisiae
enzymes were active TPK we developed a protocol involv-
ing four consecutive reactions and different enzymes. The
TPK activities were determined at room temperature using
purified protein (10 μg.ml-1) in Tris buffer (50 mM, pH
7.5) in presence of 1 mM thiamine and 5 mM ATP. The
reaction cascade was monitored through the NADH
decrease in absorbance at λ = 334 nm. The first reaction is
catalyzed by the TPK and produces a TPP and an AMP. The
myokinase then uses the produced AMP in the presence of
ATP to produce 2 ADP molecules, each of them being
used by the pyruvate kinase enzyme in presence of phos-
phoenol pyruvate (PEP) to produce a pyruvate and an ATP
molecule. The last step is catalyzed by the lactate dehydro-
genase hydrolyzing pyruvate in the presence of NADH to
produce L-lactate and NAD+.
Crystallisation
The  C. albicans TPK recombinant protein was concen-
trated to 20.4 g/L in 10 mM Tris buffer at pH 8.0 using a
centrifugal filter device (Ultrafree Biomax 30 K, Millipore,
Bedford MA, USA). Precipitation experiments were carried
out at 293 K using various precipitating agents (i.e.
AmSO4, PEG, NaCl, MPD) at various pHs (i.e. 5, 6, 7, 8,
9) to determine the optimal protein concentration for
crystallization. The screening for crystallization condi-
tions was performed on 3 × 96-well crystallization plates
(Greiner) loaded by an 8-needle dispensing robot (Tecan,
WS 100/8 workstation modified for our needs), using a 1
μl sitting drop per condition at 293 K. The tested 576 crys-
tallization conditions include in-house designed [13] and
commercially available solution sets (MDL Structure-
Screen, Wizard-Emerald BioSystems).
The TPK protein (10.2 g.l-1, buffer Tris 10 mM, pH 8.0)
was then incubated with AMP-PNP (1 mM) and/or thia-
mine (5 mM) for few minutes and the best crystals of each
protein/ligand complex were obtained using the hanging
drop vapor diffusion method with a 1 ml reservoir. Crys-
tallization droplets were made of 0.5 μl of complex mixed
with 0.5 μl of the reservoir solution made of 17.5 to 20 %
PEG4000, MgCl2  0.2 M, Tris 0.1 M, 20 % Glycerol
between pH 7.0 and 7.5. Crystals appeared within a few
days.
Data collection
Crystals of the TPK protein were collected in a Hampton
Research 0.2 mm3 loop, flash frozen to 100 K in a cold
nitrogen gas stream and subjected to X-rays. A first data set
was collected from a crystal of TPK incubated with thia-
mine on a MarCCD (165 mm) camera at the European
Synchrotron Radiation Facility (ESRF) on the BM30A-FIP
beamline at a wavelength of 0.954 Å. A second data set
corresponding to a crystal of TPK incubated both with thi-
amine and AMP-PNP was collected at ESRF on ID29
beamline on an ADSC Q210 2D detector at a wavelength
of 0.98 Å. The diffraction data were indexed with MOS-BMC Structural Biology 2008, 8:33 http://www.biomedcentral.com/1472-6807/8/33
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FLM [14] and scaled with the SCALA [15] software from
the CCP4 suite [16]. The two crystals belong to the space
group P1 with two molecules in the asymmetric unit. All
statistics of the processed data are summarized in table 1.
Structure determination
The C. albicans TPK crystal structure in complex with thia-
mine has been determined by molecular replacement
using the CaspR server [17,18]. To generate the C. albicans
TPK models, we used the available three-dimensional
structures of Saccharomyces cerevisiae and Mus musculus thi-
amine pyrophosphokinase (PDB id 1IG0 and 1IG3) as
template and TPK related sequences from other species
(Swiss-Prot id Q9H3S4, P41888). MODELLER produced
15 models which were screened for a molecular replace-
ment solution using 15 to 3 Å data and the AMoRe soft-
ware [19]. The space group was first misinterpreted as C2
with one monomer per asymmetric unit and cell parame-
ters of a = 109.15 b = 50.83 c = 63.81, β = 116.18. The
structure was solved in this space group. The best model
produced a solution with one monomer and a correlation
of 29.3% and a R-factor of 53.7% prior to CNS refine-
ment. After one round of rigid-body refinement and min-
imization using the CNS program [20] with 15 to 3 Å
data, the R-factor dropped to 42% with a 50% Rfree. Rap-
idly, the refinement stopped converging and we suspected
wrong symmetry assignation. We thus reprocessed the
TPK/thiamine/AMP-PNP data in P1 space group and com-
Table 1: X-ray data collection (ESRF) and refinement statistics
Data collection TPK Thiamine-PNP TPK Thiamine
Beam line ID29 BM30A
Wavelength (Å) 0.98 0.954
Space group P1 P1
Unit cell (Å) a = 50.825 b = 60.331 c = 63.722 a = 51.309 b = 60.696 c = 64.831
100 K α = 66.144 β = 89.941 γ = 65.067 α = 65.937 β = 89.858 γ = 64.868
Resolution range (Å)(highest resolution shell) 29.45 to 1.96(2.03 to 1.96) 50.19 to 2.1(2.21 to 2.1)
Observations 70690 (104) 68171 (8700)
Unique reflections 35345 (52) 33349 (4258)
Multiplicity1 1.9 (1.0) 2 (2)
Completeness1 92.8 (60.3) 96.1 (85.4)
<I/σI>1,2 14.5 (3.8) 7.9 (7.1)
Rsym (%)1,3 3.5 (19.5) 4.7 (8.3)
Refinement 2G9Z 2HH9
Rcryst (%)4 18.7 (31) 18.1 (21)
Rfree (%) 23.6 (33) 25.4 (26)
Δbond (Å) 0.022 0.05
Δangle (°) 1.934 1.2
N° Protein atoms 4776 4786
N° water 520 660
N° Heterogen atoms 62 40
Average B factor (Å2) 26.9 26.2
Protein main chain 26 25.9
Water 41 45.8
Ligand 18.1 20.4
Mg2+ 23.58 8.4
PO4 31.6
Cl- 29.8
Ramachandran plot (%)
Most favored 79.2 76.0
Allowed 9.0 11.8
Generously allowed 0.3 0.3
Disallowed regions 0.3 0.3
1 values in parentheses are for the highest resolution shell.
2 < I/σI>, is the mean signal to noise ratio, where I is the integrated intensity of a measured reflection and σ is the estimated error in the 
measurement.
3 Rsym = ∑h ∑i|Ih, i - &#x3008;Ih&#x3009;|/∑h ∑i|Ih, i, where I is the integrated intensity of reflection h having i observations and &#x3008;Ih&#x3009; is 
the mean recorded intensity of reflection h over multiple recording.
4 Rcryst = ∑||Fo|-|Fc||/∑|Fo|, where Fo are observed and Fc calculated structure factor amplitudes. Rfree is calculated from a randomly chosen 9.9% of 
reflections.BMC Structural Biology 2008, 8:33 http://www.biomedcentral.com/1472-6807/8/33
Page 5 of 14
(page number not for citation purposes)
puted a self-rotation function using AMoRe which
resulted in a peak corresponding to a two-fold pseudo
symmetry with a correlation coefficient of 93.4% using
data between 15 and 2 Å thus confirming the P1 space
group. The two monomers, related by a non crystallo-
graphic symmetry (NCS), mainly present differences in
flexible loops and water molecules. The model was man-
ually corrected using TURBO-FRODO [21] followed by
several rounds of minimization and individual B-factors
refinements using 29.45 to 1.96 Å data and the CNS soft-
ware. 520 water molecules were built into the model as
well as a thiamine-PNP molecule, three Mg2+ and one Cl-
ion per monomer. Some residues were still disordered in
loops L1, L2 and L4 and are absent from the deposited
structure. The final free and working R-values are 23.6%
and 18.7% respectively.
The refined structure was then used against the TPK/thia-
mine data and refinement was performed using several
manual rebuilding cycles followed by minimization and
B-factor refinement using COOT [22] and REFMAC [23].
660 water molecules were built into this model as well as
a thiamine molecule and two Mg2+ ions per monomer.
Again, some residues were still disordered in loops L1, L2,
L4 and L11 and are absent from the deposited structure.
The final free and working R-values are 25.4% and 18.1%
respectively.
Results
TPK activity of the C. albicans recombinant protein
The activity of the S. cerevisiae TPK protein was previously
measured on the native protein extracted from yeast [2].
To validate our indirect enzymatic assay, we used the S.
cerevisiae enzyme as a TPK activity control. Under the con-
ditions described in the methods section we measured
specific activities of 0.266 nM/min/mg for the S. cerevisiae
enzyme (compared to 0.27 nM/min/mg for the native
enzyme [2]) and of 0.367 nM/min/mg for the C. albicans
recombinant protein.
The CA1462 overall structure: monomer
As expected, the overall structure of the Candida albicans
TPK is similar to other members of the Thiamine pyro-
phosphokinase family. CA1462 is a homodimer, with
each monomer constituted of two domains. The D1
domain (Figure 1A, see Additional file 2) is an αβ fold
with a twisted β-sheet made of six parallel strands (β 3 to
β 8) surrounded by six helices (α11 to α6). The D2 domain
is a β sandwich composed of two layers arranged in a jelly-
roll topology (Figure 1A, see Additional file 2). Antiparal-
lel strands β 1, β 10, β 12, β 13-β 14, β 16, and β 2 parallel to
β10 constitute the first layer. Antiparallel strands β 9, β 11,
β 15 and β 17 constitute the second one. Both domains con-
tribute to the dimeric association with a 1920 Å2 buried
surface area.
Overall structure of the C. albicans TPK enzyme Figure 1
Overall structure of the C. albicans TPK enzyme. A) 
The first monomer is represented in blue and the second 
monomer is in yellow for β-sheets, in red for helices and in 
green for loops. D1 corresponds to the αβ domain and D2 
to the β-sandwich domain. Representation of the B-Factor 
values on the structure of C. albicans TPK in complex with 
thiamine (B) or Thiamine-PNP (C). The tube radius is corre-
lated with B-factors values (high, large tube and small, thin 
tube). Structures are color coded according to secondary 
structure elements (red for helices and yellow for β-strands). 
Ligands are represented in blue. All the structure representa-
tions were generated using PYMOL [34].BMC Structural Biology 2008, 8:33 http://www.biomedcentral.com/1472-6807/8/33
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We used the 3D-COFFEE server [24,25] to perform a struc-
tural alignment of 23 selected TPK sequences of various
origins using CA1462, Saccharomyces cerevisiae (PDB id
1IG0) [8] and Mus musculus (PDB id 2F17) [7] TPK as
structural templates. Despite the high variability among
these TPK sequences (20% to 45% identity with CA1462),
there is strong residue conservation around the catalytic
center (Figure 2, see Additional file 3). Four aspartates are
strictly conserved (D78, D113, D115, D142, according to
the C. albicans TPK numbering) and have already been
proposed to be involved in the stabilization of the ATP
molecule through Mg2+ contacts [8]. An aromatic residue
is always found at position 285 (Y285 in C. albicans) and
is known to participate in the thiamine stabilization [26].
An asparagine residue (N302) is strictly conserved but its
function is not yet understood. This residue is close
enough to the thiamine substrate to make some contacts
with its amidopyrimidine ring.
Interestingly, there are three loops in the C. albicans TPK
structure. Two of them, L4 and L11 (Figure 2), are unique
to C. albicans, while the third and longest insert (L8-α5-L9)
is also present in the yeast homolog with which it shares
less than 20% identity over 35 residues (Figure 2). None
of these fragments appear to be directly involved in the
catalytic reaction or in the ligands binding (Figure 2). In
the structure, the L11 loop lies in the solvent, in an open
conformation and away from the rest of the molecule
(Figure 1B–C). The B-factors for this loop are also very
high (see Additional file 4). We first built an approximate
loop by following the residual density present in the 2Fo-
Fc and Fo-Fc maps. We then used manual docking to ver-
ify that the length and geometry of this loop was compat-
ible with a transient interaction with the ligands. This
loop may thus play a role during the binding of the sub-
strates, or in the pyrophosphorylation mechanism itself.
The CA1462 overall structure: dimer
The main differences between the two monomers related
by the NCS involve flexible loops disordered in the crystal
structure (Figure 1B–C, see Additional file 4). They
include loops L1, L2 and L4, which are too distant to be
involved in the active site formation and located too far
from symmetry related molecules to possibly be directly
involved in the crystal packing. There are also water mol-
ecules which are not strictly symmetrical between the two
monomers (data not shown). Although the loop L11 is
highly mobile and associated with high B-factors (Figure
1B-C, see Additional file 4) it presents little differences
between the two monomers. The L8-α5-L9  fragment,
which is involved in crystal packing through interactions
between L8-α5 helix/turn and α3-β6 helix/turn in the two
monomers, can be superposed with less than 0.3 Å root
mean square deviation (RMSD) based on α carbon (Cα)
superposition.
There are no major differences between the TPK known
structures based on Cα superposition using LSQMAN
[27]. RMSD are 2.33 Å (534 superimposed residues)
between the C. albicans and the S. cerevisiae TPK structures,
and 2.62 Å (464 superimposed residues) between the C.
albicans and the Mouse TPK. The backbone trace around
the thiamine binding site superimposes well except for
one fragment. Timm et al. described a rearrangement of
the L6 loop in the mouse TPK when comparing the struc-
tures with thiamine and TPP [7]. This rearrangement is
not observed within the C. albicans TPK which fits the
mouse TPK in complex with TPP except for the S116 side
chain.
Thiamine binding site (PDB id 2HH9)
Two binding sites can be shown in the asymmetric unit.
The strong electronic density is consistent with thiamine
molecules present at the thiamine binding site (Figure
3A). As in the mouse structure, the thiamine moieties are
located at an extremity of the groove formed by the dimer
assembly. For convenience, we will take A as the reference
monomer and B as the second one (according to the
deposited PDB structures) but all observations made on
one of the active sites can be transposed to the second one.
The ligands are maintained by both main chains and side
chains interactions. These interactions involve the strands
β13, β14, β15, of monomer B and the loops L6, L7 of mono-
mer A.
As observed in other structures (PDB id 2G9Z, 1IG3 and
2F17) there is a weak stacking between an aromatic resi-
due (Y285B in CA1462) and the amidopyrimidine ring
(Figure 4A–C). The CM2 carbon makes hydrophobic
interactions with the W290B side chain, a residue con-
served in the sequence of the S. cerevisiae homologue. In
the mouse sequence this residue is replaced by an aspar-
tate and does not make any contact with the ligand. Nev-
ertheless, a certain hydrophobic environment is
maintained in the murine structure with the spatial prox-
imity of a leucine (L204). The thiamine ammonium
group N4 of the amidopyrimidine ring is engaged in a salt
bridge with the Q138A main-chain carbonyl oxygen (Fig-
ure 4A). The opposite side of this ring is stabilized by
another salt bridge involving N1 and the oxygen from the
S299B side chain (Figure 4A). The aspartate residue inter-
acting with N4 and N3 described in the mouse structures
[26] is replaced by a tyrosine (Y139B) too far away from
the ring to interact with it. N5 from the thiazolium ring is
stabilized by electrostatic interactions between the main
chain carbonyl oxygen atoms of S300B and Q138A.
At least 2 residues involved in the thiamine binding
pocket (Y139A, W290B) are poorly conserved between
different species but well represented in fungus (align-BMC Structural Biology 2008, 8:33 http://www.biomedcentral.com/1472-6807/8/33
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Multiple structural alignment of TPK sequences Figure 2
Multiple structural alignment of TPK sequences. Mouse in blue (PDB id 2F17), Candida albicans SC5314 in red (Swiss-
Prot id CA1462), Saccharomyces cerevisiae in green (PDB id 1IG0), Human (Swiss-Prot id Q9H3S4), Bovine (Swiss-Prot id 
Q5E9T4), Caenorhabditis elegans (Swiss-Prot id P30636), Bacillus subtilis (Swiss-Prot id O34664], Geobacillus kaustophilus (Swiss-
Prot id Q5L0R6), Bacillus cereus (strain ZK/E33L) (Swiss-Prot id Q636G7), Bacillus thuringiensis subsp. Konkukian (Swiss-Prot id 
Q6HEV6), Bacillus cereus (strain ATCC 14579/DSM 31) (Swiss-Prot id Q819U8), Staphylococcus aureus (strain COL) (Swiss-
Prot id Q5HGL0), Streptococcus pyogenes serotype M6 (Swiss-Prot id Q5XDX1),Enterococcus faecalis (Swiss-Prot id Q82ZE3), 
Clostridium tetani (Swiss-Prot id Q895P3), Fusobacterium nucleatum subsp. vincentii ATCC 49256 (Swiss-Prot id Q7P831), Fuso-
bacterium nucleatum subsp. nucleatum (Swiss-Prot id Q8RF31), Thermoanaerobacter tengcongensis (Swiss-Prot id Q8R9T9), Fran-
cisella tularensis subsp. Tularensis (Swiss-Prot id Q5NFC3), Silicibacter pomeroyi (Swiss-Prot id Q5LTU1), Porphyromonas gingivalis 
(Swiss-Prot id Q7MTP9), Symbiobacterium thermophilum (Swiss-Prot id Q67QK6), Brucella melitensis (Swiss-Prot id Q8YJ01). 
Secondary structures are numbered as in C. albicans. Strictly conserved residues are boxed with a thin blue line. C. albicans TPK 
residues making contacts with Mg2+ ions are highlighted in brown, those in contact with phosphate and Mg2+ in green, those in 
contact with thiamine or thiamine-PNP in pink, and those in contact with thiamine or thiamine-PNP and Mg2+ in purple. The 
residues exclusively interacting with thiamine-PNP (and not thiamine) are in grey, and those in contact both with thiamine-PNP 
and phosphate are in light blue.BMC Structural Biology 2008, 8:33 http://www.biomedcentral.com/1472-6807/8/33
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Ligands electronic density map and Mg2+ coordination Figure 3
Ligands electronic density map and Mg2+ coordination. 2fo-fc electronic density map of thiamine contoured at 1 sigma 
(A) and coordination of each Mg2+ ion in the TPK/thiamine complex (B-C). Fo-Fc electronic density map contoured at 1.5 
sigma (displayed in green) of TPNP (D) with Mg2+ and PO43-. This map was computed using the refined structure where all lig-
ands have been removed. Coordination of each Mg2+ ion in the TPK/thiamine-PNP complex (E-G). Magnesium are represented 
as white spheres, water molecules as cyan spheres, oxygen atoms are in red, nitrogen in blue and carbon in green. Mg2+ coor-
dinations are marked with magenta dashed lines.BMC Structural Biology 2008, 8:33 http://www.biomedcentral.com/1472-6807/8/33
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Stereo view of the superposed ligand binding sites from different species Figure 4
Stereo view of the superposed ligand binding sites from different species. The superposition was obtained using as 
reference structure (in yellow) the C. albicans TPK co-crystallised with TPNP (PDB id 2G9Z) and A) S. cerevisiae (Blue) (PDB id 
1IG0), B) Mouse (green) (PDB id 2F17) C) C. albicans TPK co-crystallised with thiamine (red) (PDB id 2HH9). Residue numbers 
correspond to C. albicans numbering.BMC Structural Biology 2008, 8:33 http://www.biomedcentral.com/1472-6807/8/33
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ment not shown) and could be the focus of specific anti-
fungal drug design.
Magnesium binding site in the TPK/Thiamine complex
As observed in the mouse TPK/TPP complex, an Mg2+ ion
is maintained by electrostatic interactions with the side
chain of the four strictly conserved aspartate residues
(D78, D113A, D115, D142). The 2 last coordinations are
made with water molecules 92 and 69 (Figure 3B, Mg2+
number 1).
Timm et al. highlighted that a second Mg2+ ion could be
involved in the reaction process as in another pyrophos-
phokinase (HPPK). Interestingly, the C. albicans TPK/thi-
amine complex reveals a second Mg2+ partially stabilized
by the hydroxyl group O1 of thiamine and a salt bridge
with D113 and D142 side chains and with two main
chain carboxy oxygens (Y140, N141). The nitrogen atom
from the K145 side chain participates in the last coordina-
tion (Figure 3C, Mg2+ number 2). As proposed by Timm et
al., this lysine could be involved in the activation of the
thiamine hydroxyl by the stabilization of a water mole-
cule [7] or, as in this C. albicans structure, of a magnesium
ion.
Thiamine-PNP binding site, implications for the ATP 
binding site (PDB id 2G9Z)
In order to compare the C. albicans and mouse TPK bind-
ing sites, we used 2 ATP analogues (AMP-CPP and AMP-
PNP) during the crystallization process. In the AMP-CPP
molecule a carbon atom replaces the oxygen atom located
between the α and β phosphates in the ATP molecule
(O3). In the AMP-PNP molecule, a nitrogen atom (N3)
replaces O3. While we did not get crystals of the TPK/Thi-
amine/AMP-CPP complex, the TPK incubated with thia-
mine and AMP-PNP produced usable crystals. However,
the structure revealed that instead of a TPK/Thiamine/
AMP-PNP complex, we obtained an unexpected TPK/thi-
amine-PNP complex with a TPNP molecule in the enzyme
binding site (Figure 3D). This result is consistent with the
earlier suggestion that the pyrophosphate group is trans-
ferred at once from the ATP molecule to the thiamine
moiety.
The superimposition of the C. albicans TPK/TPNP com-
plex onto the mouse TPK/TPP complex (PDB id 2F17)
highlights few differences between the two thiamine
phosphate ends. The nitrogen N3 in the TPNP molecule is
symmetrically opposed to its equivalent oxygen O3 in the
TPP molecule. It is stabilized by a weak electrostatic inter-
action (3.28 Å) with the S301B γ-oxygen in the C. albicans
TPK/TPNP complex (Figure 4). In the mouse TPK/TPP
complex, this serine residue, located in the AMP binding
pocket, is at 4.44 Å from the O3. We propose that this ser-
ine residue could repulse the TPP in normal conditions
and help to release it out of the active site. In the Mouse
TPK/TPP complex, Q134A interacts directly with the
phosphate end of the thiamine. The equivalent glutamine
(Q206A) adopts the same conformation in the C. albicans
TPK/thiamine complex and an opened conformation in
the C. albicans TPK/TPNP complex.
In the mouse TPK complex with AMP and TPP [7], the
ATP binding site involves residues poorly conserved
across different species. In the C. albicans TPK structure, no
extra density that could correspond to a nucleotide was
found even if this site is opened enough to accommodate
an ATP molecule.
Interestingly, exactly opposed to the mouse AMP binding
site, (Figure 5A, see Additional file 3), we have identified
an inorganic phosphate (Pi) (average B-factor of 30 and
occupancy of 1). This phosphate is stabilized by a
Glutamine (Q138A), an Arginine (R303B) and a salt
bridge involving a magnesium ion (described later).
Moreover, despite the lack of strong residual density, an
AMP molecule could reasonably be accommodated at
that position with an average B-factor of 50 and a good
occupancy (0.8). However, the non-phosphate part of this
putative AMP molecule presents higher B-factors (around
60) and interacts with side chains of poorly conserved res-
idues (see Additional file 3): R134A, Q138A and S136A
directly or through a water molecule bridge. It also inter-
acts with the carbonyl oxygen of D113A.
In the C. albicans thiamine complex, 2 water molecules
take the place of oxygen atoms from the proximal thia-
mine phosphate. Similarly to the S. cerevisiae apo form, a
third water molecule occupies the same position as the
distal thiamine phosphorus atom in the Thiamine-PNP
complex.
The side chain of the Q138 can adopt two alternative con-
formations: the one observed in S. cerevisiae or mouse TPK
(PDB id 1IG0, 2F17) and the one observed uniquely in
the C. albicans TPK/TPNP complex (Figure 5B). In the lat-
ter conformation, Q138 does not interact with the inor-
ganic phosphate described above.
Magnesium binding site in the TPK/TPNP complex
Three magnesium ions are stabilized in the active site. The
first two ions superimpose exactly with the ones co-crys-
tallised in the C. albicans TPK structure with thiamine.
One is coordinated through the δ-oxygen of each of the
four conserved aspartates and the oxygen of the proximal
phosphate in TPNP. The sixth Mg2+ coordination involves
a water molecule in C. albicans TPK instead of the AMP-
phosphoryl in the mouse structure (Figure 3E, Mg2+
number 1). The second one is stabilized by the same inter-
actions as in the thiamine/TPK complex except for the O1BMC Structural Biology 2008, 8:33 http://www.biomedcentral.com/1472-6807/8/33
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AMP binding site Figure 5
AMP binding site. A) Stereo view of the binding site symmetry in the C. albicans TPK (green) superposed on the mouse TPK 
(red). Hypothetical AMP is represented with brown lines. B) Stereo view of the 2 alternative conformations of Q138A (gate-
keeper) in grey with TPNP (green), Mg2+ (white) and AMP (brown lines) in the potential secondary binding site.BMC Structural Biology 2008, 8:33 http://www.biomedcentral.com/1472-6807/8/33
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atom of the thiamine which is involved in a thiamine-
PNP ester bond rather than an hydroxyl group in thia-
mine (Figure 3F, Mg2+ number 2).
The third magnesium ion is coordinated by the δ-oxygen
from D113 and D115 and one oxygen atom from each
phosphate group of the thiamine-PNP. The last coordina-
tion of this Mg2+ involves an oxygen atom from the free
inorganic phosphate symmetrically positioned with
regard to the AMP phosphate shown in the mouse ATP
binding site (Figure 3G, Mg2+ number 3).
Discussion
Identification of a potential secondary binding site
Timm et al. described the 3D structure of the mouse thia-
mine pyrophosphokinase co-crystallized with AMP,
pyrithiamine pyrophosphate (PPP) and magnesium ions
[7]. Their results confirmed that the AMP (and maybe the
ATP) is maintained in the protein by interactions with res-
idues 57, 58, 77 to 79, 141 to 143, 199 to 203, 206 and
207. Although we did not obtain any nucleotide analogue
in our structures along with the TPNP and magnesium
ions, we have identified an inorganic phosphate in the
structure located differently to the AMP molecule in the
mouse TPK structure. This phosphate is diametrically
opposed to the AMP phosphoryl group described by
Timm et al. relative to the thiamine moiety (Figure 5A)
and can have two distinct origins. First, AMP-PNP is
known to be very unstable in acidic conditions and can
hydrolyze into an equivalent phosphoramidate and inor-
ganic phosphate (Sigma report [28]). Our crystals have
been obtained at pH 7.0 with a large excess of AMP-PNP,
but a partial degradation of AMP-PNP cannot be
excluded. Second, this phosphate may originate from the
AMP used in the pyrophosphorylation of the thiamine.
The co-crystallized inorganic phosphate highlights a very
high symmetry in the active site (Figure 5A). The residues
involved in this phosphate stabilization are poorly con-
served across the different known TPKs (Figure 2, see
Additional file 3). The stabilization of the non-phosphate
part of the AMP in this alternative site seems to be
restricted to the ribose part of the nucleotide, which sug-
gests the existence of a rather non specific binding site
which could accommodate nucleotides other than ATP,
namely GTP, UTP and TTP [29]. Alternatively, it could cor-
respond to a transitional site for the AMP on its path out
of the protein, or for the ATP on its way to the active site,
and thus guide the motion of this product/substrate dur-
ing the hydrolysis process.
Existence of a gatekeeper residue?
Mutational studies of the human TPK, sharing 29 % iden-
tity over 288 amino-acids with the C. albicans TPK,
showed that residues D71, D73 and D100 (corresponding
to D113A, D115A and D142A in C. albicans) play a cru-
cial role in carrying out the catalytic process, that Q96 and
D133 (corresponding to Q138A and D205A) are involved
in the binding of thiamine, and that T99 and R131 (corre-
sponding to N141A and R203A) interact with the ATP
[29]. In our structures, Q138A adopts two main confor-
mations: one opened and one closed with respect to the
active site access. The structure containing thiamine only
exhibits the closed conformation, while both are present
in the TPK/TPNP complex. As in other kinase structures,
Q138A could play the role of a gatekeeper, one of the
major determinants of the selectivity in these proteins
[30,31]. If a secondary binding site exists in the protein,
this residue could directly interact with the phosphoryl
group of the AMP and both the ribosyl and pyrimidine
part of the nucleotide (Figure 5B), thus playing a role in
the enzyme selectivity. In the event of a transitional site,
Q138A could modulate the release of AMP or the entrance
of ATP.
Hypothesis on the pyrophosphorylation mechanism in C. 
albicans TPK
The mechanism of pyrophosphorylation is not well
understood. Structural studies complemented by enzy-
matic assays and mutation experiments, could give us
insight into this process conserved in a lot of species.
Baker et al. [8] proposed that, in yeast TPK, the three aspar-
tates corresponding to D78A, D113A, A142A could play
the same role as in the HPPK (6-Hydroxymethyl-7,8-dihy-
droprotein pyrophosphokinase). In this enzyme, the
pyrophosphate (PPi) is transferred from an ATP to an HP
(6-Hydroxymethyl-7,8-dihydroprotein) through a one
step pyrophosphorylation mechanism. The PPi is main-
tained in the proper conformation by two aspartates
through the coordination of two Mg2+ ions [32].
In an attempt to co-crystallize TPK with its two substrates
or in an intermediate state, we used AMP-PNP and AMP-
CPP, two ATP analogues. In the AMP-PNP, the bond
between  β and γ phosphates is non-hydrolysable,
excepted under acidic conditions, whereas in AMP-CPP it
is the bond between α and β phosphates which is non-
hydrolysable. Our attempts to co-crystallize AMP-CPP or
AMP-PNP with the enzyme have failed. Nevertheless,
using AMP-PNP, as suggested by the electronic density
maps, the PNP group was transferred to the thiamine to
form a thiamine-PNP. This observation is consistent with
a one step PPi transfer. A steady-state kinetics study of the
human TPK led to the proposal that the mechanism is a
ping-pong reaction [29] as proposed for yeast [33].
According to our results, and in agreement with Timm et
al., the possibility to co-crystallize the two substrates at the
same time is inconsistent with an ordered ping-pong
mechanism where the thiamine binds the enzyme after
ATP has been hydrolyzed and the AMP released. Moreo-BMC Structural Biology 2008, 8:33 http://www.biomedcentral.com/1472-6807/8/33
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ver, the presence and position of a possible secondary
AMP binding site is more likely to support a mechanism
where the AMP is released after the PPi transfer and before
the TPP molecule.
To our knowledge, this study is the first to report more
than one magnesium ion in the TPK active site with one
or two additional Mg2+ properly positioned to participate
in the pyrophosphorylation process in a mechanism akin
to the one proposed by Timm et al. [7]. Where Timm et al.
showed a water molecule, our structures exhibit a magne-
sium ion at a strategic location. After the binding of an
ATP molecule, K145A, a strictly conserved lysine, could
activate the thiamine hydroxyl extremity through the
coordination of the first Mg2+. At the same time, the 4
aspartates (78A, 112A, 115A and 142A) could activate the
PPi moiety of the ATP molecule. The transfer could then
take place. Each C. albicans structure reveals new positions
suggesting that 3 Mg2+ ions could be involved in the PPi
transfer mechanism. The third Mg2+ could stabilize the PPi
during the transfer.
Conclusion
In summary, we have determined the X-ray structure of
the C. albicans thiamine pyrophosphokinase co-crystal-
lized with the thiamine or the thiamine-PNP and an inor-
ganic phosphate. These different structures allow us to
describe several original features. The active site symmetry
and the inorganic phosphate binding site suggest the pres-
ence of an alternative binding site in C. albicans TPK, or at
least a transitional position of the substrate/product along
the reaction pathway. This also suggests an enzymatic
process where both products, TPP and AMP, are present at
the same time in the protein with the release of the AMP
molecule preceding the release of the TPP. We propose
that the Q138A could interact with both substrates and
products and work as a gatekeeper, modulating the activ-
ity of the enzyme (as observed in other kinases). The crys-
tallization of thiamine-PNP at the TPK active site strongly
suggests that the pyrophosphorylation process is a one
step mechanism. K145A seems to be important in the cat-
alytic process and substrate activation. The presence of
two or three magnesium ions at the same time in the
active site in these structures suggests a catalytic reaction
similar to the one described for HPPK, also performing
pyrophosphate transfer. The PPi transfer mechanism at
work in thiamine pyrophosphokinases could be further
explored by studies focusing on mimicking the transition
state.
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Footnotes
The atomic coordinates and structure factors for the crys-
tal structures of the thiamine pyrophosphokinase from
Candida albicans in complex with thiamine or thiamine-
PNP are available in the RCSB Protein Data Bank under
PDB id 2HH9 and 2G9Z respectively.
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